Stay updated on CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record now shows the recruitment status as No longer looking for participants, signaling that enrollment has ended. The version history includes a new Revision: v3.6.0 and removes Revision: v3.5.5, updating how the record's changes are tracked over time.
    Difference
    0.4%
    Check dated 2026-06-13T18:23:44.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A new revision entry v3.5.5 was added to the record history. The previous v3.5.4 entry was deleted.
    Difference
    0.1%
    Check dated 2026-06-06T14:13:28.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    A new revision entry (v3.5.4) was added to the record history, superseding the previous version (v3.5.3) and updating the page's version history.
    Difference
    0.1%
    Check dated 2026-05-15T23:56:43.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page’s UI revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a system/interface update rather than a change to the study record contents.
    Difference
    0.1%
    Check dated 2026-04-24T22:17:26.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:45:45.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 to the history and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T20:46:31.000Z thumbnail image

Stay in the know with updates to CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page.